top of page
Search
Londa Rohlfing

Health Care Integrity with Amy Miller and Rolf Hazlehurst

A more detailed report will be added here once our notes have been approved for accuracy by our speakers.



Guest Speakers for this VERY informative (and sad, plus alarming) meeting were as follows.     


   Amy Miller is the Director of Marketing for Reform Pharma, an Initiative of Children’s Health Defense. The mission of Reform Pharma is to remove Big Pharma corruption and restore healthcare integrity.  Amy is a longtime advocate for medical freedom and is passionate about creating change through legislation. Her legislative work in Tennessee was instrumental in stopping vaccination of minors without parental consent. Amy is a former business owner and co-founded Tennessee Coalition for Vaccine Choice. 


Rolf Hazelhurst a native Jacksonian is the Senior Staff Attorney for CHD. He graduated from the University of Tennessee and also attended  St. John’s College in Oxford, England. He received his Juris Doctorate degree from the University of Memphis and has been actively engaged in the practice of law since 1995. He has been admitted to practice law in multiple courts, including the Supreme Court of the United States.Before joining CHD, he was an Assistant District Attorney General for the State of Tennessee. As a criminal prosecutor for over 14 years, Rolf gained extensive jury trial experience while prosecuting almost every criminal offense from minor misdemeanor offenses to the most serious violent felonies including first degree murder. Since 2003, Rolf has fought for the rights of vaccine-injured children. His son’s case Hazlehurst v. H.H.S. was the second test case in the Omnibus Autism Proceeding under the National Childhood Vaccine Injury Compensation Program. He intends to devote the remainder of his life to bringing the truth to light regarding the catastrophic injuries and injustices caused by the National Childhood Vaccine Injury Compensation Act of 1986.






Read all about Rolf's lawsuit at this link:

5 views0 comments

Comments


bottom of page